Dyslipidaemia is one of the most common conditions in clinical practice and a major risk factor for atherosclerotic disease. Clinicians should be skilled in screening, diagnosis, risk stratification, and management. Lifelong control of dyslipidaemia requires regular monitoring of treatment targets and ongoing optimization of therapy to reduce atherosclerotic burden.